Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
NCT01083563 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2015-04-08
Summary
The purpose of this study is to examine the effect of anti-TNF therapy on rheumatoid arthritis using magnetic resonance imaging (MRI) and ultrasound imaging.
Anti-TNF therapies include a group of medications such as Enbrel, Remicade and Humira that affect your body's inflammatory response. These medications are routinely prescribed for the treatment of rheumatoid arthritis.
Conditions
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Principal Investigators
-
Christopher Ritchlin, MD / MPH · University of Rochester
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- United States
Study Locations
More Related Trials
-
Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
NCT01602302 ·Status: TERMINATED ·Phase: PHASE4
-
Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants
NCT01009879 ·Status: WITHDRAWN ·Phase: PHASE4
-
Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment
NCT00929357 ·Status: COMPLETED
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
NCT01783015 ·Status: TERMINATED ·Phase: PHASE4
-
Very Early Versus Delayed Etanercept in Patients With RA
NCT02433184 ·Status: COMPLETED ·Phase: PHASE4
-
Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
NCT00796705 ·Status: TERMINATED ·Phase: PHASE4
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab
NCT01981473 ·Status: COMPLETED
-
Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA
NCT05246280 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis
NCT01394913 ·Status: WITHDRAWN ·Phase: PHASE3
-
Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients
NCT02476084 ·Status: COMPLETED
-
Leflunomide in Rheumatoid Arthritis
NCT00280644 ·Status: COMPLETED ·Phase: PHASE4
-
Prediction of Erosive Disease in Early Rheumatoid Arthritis (RA) by Ultrasound and Cartilage Biodegradation Markers
NCT02464384 ·Status: UNKNOWN ·Phase: NA
-
Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study
NCT01659242 ·Status: TERMINATED ·Phase: PHASE4
-
Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?
NCT02908490 ·Status: TERMINATED ·Phase: PHASE2
-
Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study
NCT00522184 ·Status: COMPLETED ·Phase: PHASE3
-
Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents
NCT01691014 ·Status: TERMINATED
-
Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis
NCT00037700 ·Status: COMPLETED ·Phase: PHASE2
-
Scintigraphy for Prediction In Rheumatoid Intentional Therapy Tapering
NCT05983848 ·Status: NOT_YET_RECRUITING
-
Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission
NCT02373813 ·Status: COMPLETED ·Phase: PHASE3
-
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
NCT02878161 ·Status: UNKNOWN ·Phase: PHASE4
-
An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.
NCT02590562 ·Status: COMPLETED
-
A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis
NCT00484237 ·Status: COMPLETED ·Phase: PHASE3
-
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis
NCT00361634 ·Status: COMPLETED ·Phase: PHASE1